Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive efforts to increase adherence to statin therapy.
Vonbank A, Agewall S, Kjeldsen KP, Lewis BS, Torp-Pedersen C, Ceconi C, Funck-Brentano C, Kaski JC, Niessner A, Tamargo J, Walther T, Wassmann S, Rosano G, Schmidt H, Saely CH, Drexel H. Vonbank A, et al. Among authors: niessner a. Eur Heart J. 2017 Aug 21;38(32):2473-2479. doi: 10.1093/eurheartj/ehw628. Eur Heart J. 2017. PMID: 28077470 No abstract available.
Prognostic value of apoptosis markers in advanced heart failure patients.
Niessner A, Hohensinner PJ, Rychli K, Neuhold S, Zorn G, Richter B, Hülsmann M, Berger R, Mörtl D, Huber K, Wojta J, Pacher R. Niessner A, et al. Eur Heart J. 2009 Apr;30(7):789-96. doi: 10.1093/eurheartj/ehp004. Epub 2009 Feb 4. Eur Heart J. 2009. PMID: 19196721
Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score.
Goliasch G, Kleber ME, Richter B, Plischke M, Hoke M, Haschemi A, Marculescu R, Endler G, Grammer TB, Pilz S, Tomaschitz A, Silbernagel G, Maurer G, Wagner O, Huber K, März W, Mannhalter C, Niessner A. Goliasch G, et al. Among authors: niessner a. Eur Heart J. 2012 Sep;33(18):2282-9. doi: 10.1093/eurheartj/ehs164. Epub 2012 Jun 28. Eur Heart J. 2012. PMID: 22745355
C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.
Koller L, Kleber M, Goliasch G, Sulzgruber P, Scharnagl H, Silbernagel G, Grammer T, Delgado G, Tomaschitz A, Pilz S, März W, Niessner A. Koller L, et al. Among authors: niessner a. Eur J Heart Fail. 2014 Jul;16(7):758-66. doi: 10.1002/ejhf.104. Epub 2014 May 7. Eur J Heart Fail. 2014. PMID: 24806206 Free article.
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis.
Niessner A, Tamargo J, Morais J, Koller L, Wassmann S, Husted SE, Torp-Pedersen C, Kjeldsen K, Lewis BS, Drexel H, Kaski JC, Atar D, Storey RF, Lip GYH, Verheugt FWA, Agewall S. Niessner A, et al. Eur Heart J. 2017 Jun 7;38(22):1710-1716. doi: 10.1093/eurheartj/ehv676. Eur Heart J. 2017. PMID: 26705385 No abstract available.
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Schmidt M, Lamberts M, Olsen AM, Fosbøll E, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C. Schmidt M, et al. Among authors: niessner a. Eur Heart J. 2016 Apr 1;37(13):1015-23. doi: 10.1093/eurheartj/ehv505. Epub 2016 Mar 16. Eur Heart J. 2016. PMID: 26984863 Review. No abstract available.
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Schmidt M, Lamberts M, Olsen AM, Fosbøll EL, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C. Schmidt M, et al. Among authors: niessner a. Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):108-18. doi: 10.1093/ehjcvp/pvv054. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27533522 No abstract available.
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P; WG on Cardiovascular Pharmacotherapy. Agewall S, et al. Among authors: niessner a. Eur Heart J. 2017 Jan 14;38(3):143-153. doi: 10.1093/eurheartj/ehw149. Eur Heart J. 2017. PMID: 28158518 No abstract available.
Gender differences in the effects of cardiovascular drugs.
Tamargo J, Rosano G, Walther T, Duarte J, Niessner A, Kaski JC, Ceconi C, Drexel H, Kjeldsen K, Savarese G, Torp-Pedersen C, Atar D, Lewis BS, Agewall S. Tamargo J, et al. Among authors: niessner a. Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):163-182. doi: 10.1093/ehjcvp/pvw042. Eur Heart J Cardiovasc Pharmacother. 2017. PMID: 28329228 Review.
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Niessner A, Tamargo J, Koller L, Saely CH, Schmidt TA, Savarese G, Wassmann S, Rosano G, Ceconi C, Torp-Pedersen C, Kaski JC, Kjeldsen KP, Agewall S, Walther T, Drexel H, Lewis BS. Niessner A, et al. Eur Heart J. 2018 Jun 21;39(24):2274-2281. doi: 10.1093/eurheartj/ehx625. Eur Heart J. 2018. PMID: 29126266 No abstract available.
202 results